These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 12021623
1. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. Lanchote VL, Garcia FS, Dreossi SA, Takayanagui OM. Ther Drug Monit; 2002 Jun; 24(3):338-45. PubMed ID: 12021623 [Abstract] [Full Text] [Related]
5. Albendazole metabolism in patients with neurocysticercosis: antipyrine as a multifunctional marker drug of cytochrome P450. Marques MP, Takayanagui OM, Lanchote VL. Braz J Med Biol Res; 2002 Feb; 35(2):261-9. PubMed ID: 11847531 [Abstract] [Full Text] [Related]
6. Simultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma. Bonato PS, Lanchote VL, Takayanagui OM. J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan 05; 783(1):237-45. PubMed ID: 12450544 [Abstract] [Full Text] [Related]
11. Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes. Gokbulut C, Cirak VY, Senlik B. Vet Res Commun; 2006 Oct 05; 30(7):791-805. PubMed ID: 17004041 [Abstract] [Full Text] [Related]
12. Pharmacokinetic optimisation of the treatment of neurocysticercosis. Sotelo J, Jung H. Clin Pharmacokinet; 1998 Jun 05; 34(6):503-15. PubMed ID: 9646011 [Abstract] [Full Text] [Related]
13. Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity. Lima RM, Ferreira MA, de Jesus Ponte Carvalho TM, Dumêt Fernandes BJ, Takayanagui OM, Garcia HH, Coelho EB, Lanchote VL. Br J Clin Pharmacol; 2011 Apr 05; 71(4):528-35. PubMed ID: 21395645 [Abstract] [Full Text] [Related]